Clinical trials reveal a drug initially developed to treat some types of cancer now appears to help multiple sclerosis (MS) sufferers, a study said Thursday. The drug, alemtuzumab, proved effective in patient trials at reducing relapses -- a key feature of MS which sees symptoms appear sporadically. In one trial, patients who received the drug "were nearly half as likely to relapse within two years than those who received interferon", the most commonly-used ...
via Medindia Health News More READ
No comments:
Post a Comment